Appetite suppressants and valvular heart disease

被引:42
作者
Devereux, RB [1 ]
机构
[1] Cornell Univ, Med Ctr, New York Hosp, New York, NY 10021 USA
关键词
D O I
10.1056/NEJM199809103391109
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:765 / 767
页数:3
相关论文
共 13 条
[1]   Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].
Abenhaim, L ;
Moride, Y ;
Brenot, F ;
Rich, S ;
Benichou, J ;
Kurz, X ;
Higenbottam, T ;
Oakley, C ;
Wouters, E ;
Aubier, M ;
Simonneau, G ;
Begaud, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616
[2]  
Connolly HM, 1997, NEW ENGL J MED, V337, P1783
[3]   Prevention of bacterial endocarditis - Recommendations by the American Heart Association [J].
Dajani, AS ;
Taubert, KA ;
Wilson, W ;
Bolger, AF ;
Bayer, A ;
Ferrieri, P ;
Gewitz, MH ;
Shulman, ST ;
Nouri, S ;
Newburger, JW ;
Hutto, C ;
Pallasch, TJ ;
Gage, TW ;
Levison, ME ;
Peter, G ;
Zuccaro, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (22) :1794-1801
[4]   A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation [J].
Jick, H ;
Vasilakis, C ;
Weinrauch, LA ;
Meier, CR ;
Jick, SS ;
Derby, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :719-724
[5]  
JONES EC, 1998, J AM SOC ECHOCARDIOG, V11, P500
[6]   The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs [J].
Khan, MA ;
Herzog, CA ;
St Peter, JV ;
Hartley, GG ;
Madlon-Kay, R ;
Dick, CD ;
Asinger, RW ;
Vessey, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (11) :713-718
[7]  
LEBOWITZ NE, 1998, J AM SOC ECHOCARDIOG, V11, P559
[8]  
Reid Cheryl L., 1994, Circulation, V90, pI282
[9]  
SINGH JP, 1997, CIRCULATION S1, V96, P541
[10]  
*US DEP HHS, 1997, MMWR-MORBID MORTAL W, V46, P1061